METAVIA INC. Other Non-Current Liabilities
METAVIA INC. (MTVA) had Other Non-Current Liabilities of $1.00 thousand as of 2018-12-31, per its 10-Q filed 2019-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2019-11-08
- 2018-12-31: Other Liabilities, Noncurrent $1.00K.
- 2018-09-30: Other Liabilities, Noncurrent $2.00K.
- 2018-06-30: Other Liabilities, Noncurrent $3.00K.
- 2018-03-31: Other Liabilities, Noncurrent $3.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2018-12-31 | $1.00K 10-Q · filed 2019-11-08 |
| 2018-09-30 | $2.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $3.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |